-
EP1554257
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1554257
| EP1554257 - QUINAZOLINONE DERIVATIVES USEFUL AS ANTI-HYPERALGESIC AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.09.2012 Database last updated on 15.06.2024 | Most recent event Tooltip | 21.09.2012 | Application deemed to be withdrawn | published on 24.10.2012 [2012/43] | Applicant(s) | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IT
LI
LU
MC
NL
PT
Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | [N/P] |
| Former [2006/29] | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IT
LI
LU
MC
NL
PT
Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | |||
| Former [2005/29] | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IT
LU
MC
NL
PT
Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | Inventor(s) | 01 /
CULSHAW, Andrew J, Novartis Inst. for Medical S. 5 Gower Place London WC1E 6BS / GB | 02 /
DZIADULEWICZ, Edward, Novartis Inst. for Medical S 5 Gower Place London WC1E 6BS / GB | 03 /
HALLETT, Allan, Novartis Inst. for Medical S. 5 Gower Place London WC1E 6BS / GB | 04 /
HART, Terance W., Novartis Inst. for Medical S. 5 Gower Place London WC1E 6BS / GB | [2005/29] | Representative(s) | Ott, Johann Corporate Intellectual Property, Novartis AG 4002 Basel / CH | [N/P] |
| Former [2005/29] | Ott, Johann Corporate Intellectual Property, Novartis AG 4002 Basel / CH | Application number, filing date | 03757959.6 | 10.10.2003 | [2005/29] | WO2003EP11276 | Priority number, date | GB20020023730 | 11.10.2002 Original published format: GB 0223730 | [2005/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004033435 | Date: | 22.04.2004 | Language: | EN | [2004/17] | Type: | A1 Application with search report | No.: | EP1554257 | Date: | 20.07.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.04.2004 takes the place of the publication of the European patent application. | [2005/29] | Search report(s) | International search report - published on: | EP | 22.04.2004 | Classification | IPC: | C07D239/90, C07D239/95, C07D405/04, C07C229/56, A61K31/517, A61P29/00 | [2005/29] | CPC: |
C07D403/14 (EP,US);
A61P1/04 (EP);
A61P1/06 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P13/10 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P21/00 (EP);
A61P21/02 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P29/02 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07C229/56 (EP,US);
C07D239/90 (EP,US);
C07D239/95 (EP,US);
C07D405/04 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/29] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | CHINAZOLINON DERIVATE VERWENDBAR ALS ANTIHYPERALGESISCHE MITTEL | [2005/29] | English: | QUINAZOLINONE DERIVATIVES USEFUL AS ANTI-HYPERALGESIC AGENTS | [2005/29] | French: | DERIVES DE QUINAZOLINONE UTILISES COMME AGENTS ANTI-HYPERALGESIQUES | [2005/29] | Entry into regional phase | 11.05.2005 | National basic fee paid | 11.05.2005 | Designation fee(s) paid | 11.05.2005 | Examination fee paid | Examination procedure | 23.04.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 11.05.2005 | Examination requested [2005/29] | 16.11.2009 | Despatch of a communication from the examining division (Time limit: M04) | 15.03.2010 | Reply to a communication from the examining division | 03.05.2012 | Application deemed to be withdrawn, date of legal effect [2012/43] | 08.06.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/43] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.11.2009 | Fees paid | Renewal fee | 31.10.2005 | Renewal fee patent year 03 | 31.10.2006 | Renewal fee patent year 04 | 12.10.2007 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 13.10.2009 | Renewal fee patent year 07 | 12.10.2010 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.10.2011 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9811438 (TREGA BIOSCIENCES INC [US]) [A] 1,8-12 * page 1 - page 5; claims 1,2 *; | [AX]FR2167742 (ALKALINE BATTERIES LTD [GB]) [A] 1,8-12 * the whole document * * page 1 - page 4 * [X] 5; | [X]WO0170228 (MERCK & CO INC [US], et al) [X] 5 * page 34; figure SHEM.A *; | [X]WO9818781 (VERSICOR INC [US], et al) [X] 5 * page 35 - page 37 *; | [X]WO9744041 (MERCK & CO INC [US], et al) [X] 5 * page 41; figures SCHEME,A * | [AX] - EL-SHARIEF,A.M., "A COMPARATIVE STUDY OF THE BEHAVIOR OF CYANOTHIOFORMAMIDE", HETEROATOM CHEMISTRY, US, (2002), vol. 13, no. 4, pages 291 - 8, XP008026391 [A] 1 * page 291 - page 294 * * page 294 * [X] 5 DOI: http://dx.doi.org/10.1002/hc.10031 |